the aid library

LIST OPTIONS

Filter

1138

Sort by:

Direction:

Download (5248)

View PDF (7252)

Common Skin Diseases In Africa: An Illustrated Guide
recommended

Colette van Hees and Ben Naafs (2004) C1

Download (92)

View PDF (122)

Appraisal Report, HIV/AIDS Control Support Project Benin

OCSD, Social Development Department, Central and West Regions African Development Fund (2004) C2

The project will support preventive actions, traditional medicine and the coordination and implementation capacities of the national framework for HIV/AIDS control.

Download (78)

View PDF (131)

Туберкулез выявление, лечение и мониторинг по К.Томену: Вопросы и ответы

T. Frieden World Health Organization (2004) C_WHO

Поэтому уже давно возникала мысль о том,что подробный комментарий по вопросам научных знаний и практическогоопыта, лежащих в основе политики ВОЗ по борьбе ... more

Download (228)

View PDF (349)

Background Paper 6.11 Alzheimer Disease and other Dementias

B. Duthey, Ph.D; S. Tanna (2004) C2

20 February 2013 Update on 2004 Background Paper (Written by Saloni Tanna) Priority Medicines for Europe and the World "A Public Health Approach to Innovation"

Download (1242)

View PDF (2208)

Manual of Basic Techniques for a Health Laboratory
recommended

World Health Organization WHO (2003) C_WHO

Download (393)

View PDF (1696)

NATIONAL MEDICAL STANDARD FOR REPRODUCTIVE HEALTH Vol II

Government of Nepal Ministry of Health and Population Family Health Division (2003)

Download (107)

View PDF (193)

Geographical and seasonal correlation of multiple sclerosis to sporadic schizophrenia

M. Fritzsche PMC; BioMed central (2002) C2

Int J Health Geogr. 2002; 1: 5. Published online 2002 Dec 20. doi: 10.1186/1476-072X-1-5 PMCID: PMC149400 PMID: 12537588

Download (97)

View PDF (158)

Epilepsy - A manual for Medical and Clinical Officers in Africa

International League Against Epilepsy; World Health Organization; International Bureau for Epilepsy (2002) C_WHO

Download (281)

View PDF (394)

WHO Recommended Surveillance Standards AIDS

World Health Organization (2000)

Download (797)

View PDF (1255)

WHO Recommended Surveillance Standards

World Health Organization (1999)

Second editon

Download (919)

View PDF (3748)

Rapid Health Assessment Protocols for Emergencies

World Health Organization WHO (1999) C_WHO

Download (77)

View PDF (88)

Recent Advances in the Management Strategies for Buruli Ulcers

Popa G.; Muntean Al., Popa M. (2023) CC

Buruli ulcer (BU) is a bacterial skin infection that is caused by Mycobacterium ulcerans and mainly affects people who reside in the rural areas of Africa and in suburban and beach resort communities in Australia.

Download (151)

View PDF (119)

A checklist for respiratory pathogen pandemic preparedness planning

World Health Organization WHO (2023) C_WHO

This checklist is an operational tool to help national authorities develop or revise national respiratory pathogen (inclusive of influenza and coronaviruses) pandemic preparedness plans.

Download (176)

View PDF (247)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Download (112)

View PDF (90)

Public health resource pack for countries experiencing outbreaks of influenza in animals: revised guidance

World Health Organisation (WHO) (2023) C_WHO

This resource pack was developed for the country offices of the World Health Organization and national Public Health institutions, as an overview of the key information needed for advising their Member States in response to questions raised on human health due to influenza outbreaks or detections in... more

Download (103)

View PDF (87)

National Guidelines - Diagnosis, Case Management Prevention and Control of Leptospirosis

National Centre for Disease Control - Delhi (2015) C2

Diagnosis, Case Management Prevention and Control of Leptospirosis

Download (88)

View PDF (99)

Inhibición e inducción puberal en niñeces y adolescencias trans, travestis y no binaries. Documento de consenso

Pan American Health Organization (PAHO) (2023) C_WHO

Este documento de consenso brinda herramientas a los equipos de salud para acompañar modificaciones corporales vinculadas a procesos de construcción identitaria de niñeces y adolescencias trans, travestis y no binarias desde una mirada integral, basadas en la evidencia científica disponible, con... more

Download (89)

View PDF (111)

Manual de procedimientos para la vigilancia y el control de las leishmaniasis en la Región de las Américas

Pan American Health Organization (PAHO) (2023) C_WHO

La Organización Panamericana de la Salud se complace en presentar la segunda edición del Manual de procedimientos para la vigilancia y el control de las leishmaniasis en la Región de las Américas, un instrumento de apoyo a las áreas de gestión y de servicios que trabajan con la leishmaniasis e... more

Common Skin Diseases In Africa: An Illustrated Guide recommended

Manual of Basic Techniques for a Health Laboratory recommended

Common Skin Diseases In Africa: An Illustrated Guide
recommended

Manual of Basic Techniques for a Health Laboratory
recommended